Eric Lander has apologized for toasting Nobel laureate James Watson, who has espoused racist, sexist, and anti-Semitic views, Stat News reports.
Genome-wide association study hits can uncover potential therapies for conditions like inflammatory bowel disease, a Biology of Genomes speaker said.
A panel at the Biology of Genomes meeting discussed the ethical, legal, and social ramifications of germline gene editing.
Baylor College of Medicine's Olga Dudchenko sad the approach could assemble de novo mammalian genomes for less than $1,000.
In a talk at the meeting, Riken's Piero Carninci described the RADICL-seq tool he and his colleagues developed.
Stanford University's Eilon Sharon used CRISPeY to conduct a genome-wide precise editing study to study the fitness consequences of variants found in different yeast strains.
VC firm Andreessen Horowitz is putting big money into its second biology-focused investment fund in hopes of supporting engineering approaches to science.
Work presented at the Biology of Genomes meeting found that there is no one signature of dysbiosis in the gut microbiome.
Variants affecting Alzheimer's risk, cholesterol levels, and more also affect human longevity, according to a speaker at the Biology of Genomes meeting.
At the Biology of Genomes meeting, University of South Australia's Alicia Byrne described her team's work using sequencing to solve cases of perinatal death.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.